Nippon Chemiphar Co., Ltd. (TYO:4539)

Japan flag Japan · Delayed Price · Currency is JPY
1,706.00
-20.00 (-1.16%)
Apr 28, 2026, 3:10 PM JST
18.47%
Market Cap 6.15B
Revenue (ttm) 32.52B
Net Income (ttm) 545.00M
Shares Out 3.61M
EPS (ttm) 150.99
PE Ratio 11.30
Forward PE n/a
Dividend 50.00 (2.93%)
Ex-Dividend Date Mar 30, 2026
Volume 3,500
Average Volume 1,490
Open 1,709.00
Previous Close 1,726.00
Day's Range 1,680.00 - 1,709.00
52-Week Range 1,448.00 - 1,857.00
Beta 0.20
RSI 48.81
Earnings Date May 14, 2026

About Nippon Chemiphar

Nippon Chemiphar Co., Ltd., together with its subsidiaries, engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally. the company offers diagnostic products, such as IgE NC, a diagnostic kit that provides results and reveals total IgE levels, as well as 57 individual allergen reagents; and DP3000, a device for allergen-specific IgE measurements. It also develops NC-2400, a PPAR-delta agonist currently under phase 1 development; NC-2500, a XOR inhibitor for the treatment o... [Read more]

Sector Healthcare
Founded 1950
Employees 855
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4539
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.